Early immune development gives frogs edge against deadly fungus

Immunity matures at the tadpole stage, and survival follows.
Early immune development in tadpoles determines whether toad populations can survive the fungal infection that strikes after metamorphosis.

Along the lakes of the Pyrenees, where a lethal fungus has long silenced amphibian populations, some midwife toads have quietly found a way to endure — not by escaping the threat, but by meeting it earlier in life. Researchers have discovered that surviving populations develop antimicrobial defenses during the tadpole stage, before the fungus can exploit the vulnerability that comes with adulthood. In mapping this chemical armor, scientists uncovered over a thousand previously unknown peptides in toad skin, a finding that speaks not only to the resilience of nature, but to the possibility that ancient biological solutions may yet answer some of humanity's most pressing medical challenges.

  • A fungus that destroys amphibians' ability to regulate their own bodies has pushed some Pyrenean toad populations to the edge of extinction — while others, inexplicably, have begun to recover.
  • The critical window is metamorphosis: tadpoles are naturally safe, but the moment their skin keratinizes into adulthood, the fungus gains its foothold — making the timing of immune development a matter of survival or collapse.
  • Researchers found that recovering populations develop antimicrobial peptides unusually early, during the tadpole stage itself, arriving at adulthood already armed — while struggling populations lag behind, leaving their young exposed at the worst possible moment.
  • Mass spectrometry revealed 1,152 distinct peptides in toad skin, with only 7 previously known to science — a vast, largely uncharted chemical arsenal that may hold new treatments for drug-resistant infections in humans.
  • The study now pivots toward a deeper question: what triggers early immune maturation — genetics, water temperature, predator pressure — and whether that answer could be turned into medicine for our own species.

Around four Pyrenean lakes where the chytrid fungus has long devastated amphibian life, something unexpected emerged: midwife toads at three of the sites began recovering. At the fourth, the population continued to collapse. The fungus was present at all four. The difference lay somewhere inside the toads themselves.

The culprit, Batrachochytrium dendrobatidis, causes a skin disease that strips amphibians of their ability to regulate water and minerals. It is most lethal at metamorphosis — the moment tadpoles become adults and their skin keratinizes, creating the very texture the fungus consumes. Young tadpoles are naturally immune; adults are not. What happens in between determines everything.

A team from University College London, ZSL, and Imperial College London found that toads in recovering populations were developing antimicrobial peptides — short amino acid chains released by the skin as chemical defense — while still tadpoles. By the time they reached adulthood and became vulnerable, their immune systems were already prepared. In the struggling population, tadpoles produced far fewer of these peptides, leaving them defenseless at the moment of greatest exposure.

To understand the full scope of this chemical armor, researchers used mass spectrometry to analyze peptides from toad skin. The results were striking: 1,152 distinct peptides were identified, with only 7 previously documented. Toads producing a wider variety during the tadpole stage consistently survived fungal outbreaks; those with fewer did not.

The implications reach beyond conservation. Many foundational human medicines — penicillin among them — originated in the natural world, and these newly catalogued peptides represent potential leads for treating drug-resistant infections. The study, published in Nature Chemical Biology, suggests that populations devastated by disease carry within them the biological capacity to recover. The next question is what triggers early immune maturation — and whether understanding it might help us build better defenses for ourselves.

Around four lakes in the Pyrenees, where the chytrid fungus has ravaged amphibian populations for years, something unexpected happened at three of them. The midwife toads bounced back. At the fourth lake, the population continued its collapse, nearly vanishing entirely. The difference wasn't that the fungus disappeared—it remained in the water at all four sites. Something else was protecting the survivors.

Researchers from University College London, ZSL, and Imperial College London set out to understand why some populations could recover from a disease that has decimated amphibians worldwide. The culprit is Batrachochytrium dendrobatidis, a fungus that causes chytridiomycosis, a skin infection that destroys the toad's ability to regulate water, salts, and minerals. The disease is particularly lethal because it strikes at a vulnerable moment: when tadpoles metamorphose into adults and their skin becomes keratinized—the very texture the fungus feeds on. Young tadpoles are naturally safe; their skin lacks the keratin that makes adults susceptible. But once that transformation happens, they're exposed.

The team focused on antimicrobial peptides, short chains of amino acids that amphibian skin releases as a chemical defense. They discovered that toads in the recovering populations had developed these protective peptides far earlier than expected—while still in their tadpole stage. By the time they reached adulthood and became vulnerable to infection, their immune system was already battle-ready. The struggling population told a different story: their tadpoles produced far fewer of these peptides, leaving them unprepared when they matured and the fungus could attack.

Dr. Phillip Jervis, the study's lead author, explained the mechanism plainly: the disease kills toads during the transition from tadpole to adult. If immunity matures early, during the tadpole stage, the toads survive and the population endures. The question became: what determines whether a population develops immunity early or late? Jervis suggested it could be genetic, or it could be environmental—temperature, the presence of predatory trout that force tadpoles to develop faster and leave the water before their immune systems fully mature.

To map the full scope of these chemical defenses, the researchers used mass spectrometry to analyze the peptides released from toad skin. The results were startling. They identified 1,152 distinct peptides. Only seven had ever been documented before. The sheer diversity was unexpected, and it revealed something important: toads producing a wider variety of peptides during the tadpole stage survived the ongoing fungal outbreaks. Those with fewer peptides continued to suffer high mortality.

The discovery opens a door beyond amphibian conservation. Professor Alethea Tabor noted that many human medicines originated in the natural world—penicillin came from fungi, after all. These newly identified peptides are potential leads for treating human infections, particularly as antimicrobial resistance becomes an increasingly urgent problem. The ability to analyze hundreds or thousands of molecules simultaneously is a relatively recent capability, one that has transformed cancer research and is now extending into other areas of biology.

The study, published in Nature Chemical Biology, was funded by the UK's Natural Environment Research Council and the Leverhulme Trust. It suggests that populations devastated by disease aren't necessarily doomed—they possess the biological tools to recover. The question now is understanding what triggers early immune maturation, and whether that knowledge might help us design better defenses against infections in our own species.

The disease kills toads as they turn from tadpoles to adults. Getting mature immunity at the tadpole stage helps these toads survive and the population to continue.
— Dr. Phillip Jervis, UCL Chemistry and Imperial College London
These peptides are new leads that could be used to help human health, especially as we face rising antimicrobial resistance requiring new ways to treat infections.
— Professor Alethea Tabor, UCL Chemistry
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does it matter whether toads develop immunity as tadpoles versus adults?

Model

Because the fungus can only attack after metamorphosis, when the skin changes. If immunity arrives too late, the toad dies before it can mount a defense. Early development means the immune system is already waiting.

Inventor

So the three recovering populations somehow evolved faster immune development?

Model

Not necessarily evolved—it could be genetic, but it might also be environmental. Temperature, predators, food availability. Something in those three lakes is triggering earlier maturation. The fourth lake lacks that trigger.

Inventor

And you found over a thousand new peptides. Are they all useful against the fungus?

Model

That's the next question. We identified them, sequenced them. Now we need to understand which ones actually fight pathogens and how. It's like discovering a library—we know the books are there, but we haven't read them yet.

Inventor

Could these peptides help humans?

Model

Potentially. We have our own crisis with antibiotic resistance. If we can understand how these peptides work, they might inspire new drugs. Nature has been solving infection problems for millions of years. We're just learning to read the solutions.

Inventor

What happens to the fourth lake's toads?

Model

That's the hard part. Understanding what's preventing early immunity there—whether it's fixable or whether that population is simply trapped in a losing cycle. That's where the real conservation work begins.

Quer a matéria completa? Leia o original em ScienceDaily ↗
Fale Conosco FAQ